Cambrex announced today that its Snapdragon Chemistry company expanded its active pharmaceutical ingredient (API) facility in Waltham, Massachusetts. The expansion further supports the development and manufacturing of peptide therapies. East Rutherford, New Jersey-based Cambrex said its new GMP manufacturing suite increases the overall facility footprint by 20%. It also includes an ISO-7 cleanroom for preparative…